Skip to content

AIM round-up: Transense, Vela Technologies, Fevertree Drinks


London’s AIM Index has found further support during the first half of Tuesday’s session, albeit modest in quantity, adding just over two points by midday to sit at 889.11

  • Transense Technologies +31%
  • Vela Technologies +30%
  • Fevertree Drinks +11%
  • Union Jack Oil -18%
  • Inspecs Group -12%

Transense Technologies LON:TRT was leading the pack at copy time, up some 31% after the company announced pre-open that it had entered into a Memorandum of Understanding with Meggitt to evaluate licensing opportunities for its Surface Acoustic Wave sensor technology in aerospace. There has been some lumpy trade going through as a result, helping the stock recover the losses it accrued over the summer.

Vela Technologies LON:VELA also had a good morning, up 30% at 12pm. With a £5m market cap, this is something of a minnow but volumes have been significantly elevated today. An article published in the Lancet medical journal indicated a favourable – if not quite optimal – outcome for medical trials being conducted by a portfolio company. The jump today however only takes the stock back to levels seen a few months ago and is currently quoted on a significant spread.

Fevertree Drinks LON:FEVR gets the notable mention today, following the publication of interim results this morning. The company is seeing solid growth across all territories – especially mainland Europe – but management also believe it is well positioned to continue building on market share. The stock was 11% higher at midday.

Union Jack Oil LON:UJO was trading 18% lower at midday, with the publication of an independent reserves report hinting at upside potential perhaps failing to get the intended response from shareholders. However this stock has had a strong run since the end of July, suggesting this news may have acted as the trigger for some to book profits.

Inspecs Group LON:SPEC saw more selling this morning, taking the stock down 12% to fresh all time lows as a result. The downside here does seem to be the cause of some concern given recent upbeat earnings news, but the share price has lost more than 50% of its value over the last three months. Is news coming?

Looking for great investing ideas? Sign up to our free newsletter.

Join us on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top